Susceptibility to antimicrobials and mechanisms of erythromycin resistance in clinical isolates of Streptococcus agalactiae from Rio de Janeiro, Brazil [2]

Journal of Medical Microbiology

Volumn 52, Issue 11, 2003, Pages 1029-1030

  D'Oliveira, Rachel E C ^a   Barros, Rosana R ^a   Mendonça, Cláudia R V ^a   Teixeira, Lúcia M ^a   Castro, Angela C D ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFEPIME; CHLORAMPHENICOL; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; MACROLIDE; PENICILLIN G; TETRACYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT;

AGAR GEL DIFFUSION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL GENETICS; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLOOD; BRAZIL; CEREBROSPINAL FLUID; CONTROLLED STUDY; GENETIC ANALYSIS; GENOTYPE PHENOTYPE CORRELATION; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS AGALACTIAE; URINE; UTERINE ENDOCERVIX; DRUG EFFECT; HUMAN; MICROBIOLOGICAL EXAMINATION;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; HUMANS; MICROBIAL SENSITIVITY TESTS; STREPTOCOCCUS AGALACTIAE;

EID: 1542541071     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.05278-0     Document Type: Letter

References (12)

1. Centers for Disease Control and Prevention (1996). Prevention of perinatal group B streptococcal disease: a public health perspective. Morb Mortal Wkly Rep 45 (RR-7), 1-24.
2. de Azavedo, J. C. S., McGavin, M., Duncan, C., Low, D. E. & McGeer, A. (2001). Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B Streptococcus isolates from Ontario, Canada. Antimicrob Agents Chemother 45, 3504-3508.
3. d'Oliveira, R. E. C., Barros, R. R., Mendonça, C. R. V., Teixeira, L M. & Castro, A. C. D. (2003). Antimicrobial susceptibility and survey of macrolide resistance mechanisms among Streptococcus pyogenes isolated in Rio de Janeiro, Brazil. Microb Drug Resist 9, 87-91.
4. Fernandez, M., Hickman, M. E. & Baker, C. J. (1998). Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis. Antimicrob Agents Chemother 42, 1517-1519.
5. Hsueh, P.-R., Teng, L.-J., Lee, L.-N., Ho, S.-W., Yang, P.-C. & Luh, K.-T. (2001). High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan. Antimicrob Agents Chemother 45, 3205-3208.
6. Muñoz, P., Llancaqueo, A., Rodríguez-Créixems, M., Peléez, T., Martin, L. & Bouza, E. (1997). Group B streptococcus bacteremia in nonpregnant adults. Arch Intern Med 157, 213-216.
7. National Committee for Clinical Laboratory Standards (2000a). Performance Standards for Antimicrobial Disk Susceptibility Tests, 7th edn. Approved standard M2-A7. Wayne, PA: NCCLS.
8. National Committee for Clinical Laboratory Standards (2000b). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 5th edn. Approved standard M7-A5. Wayne, PA: NCCLS.
9. Seppälä, H., Nissinen, A., Yu, O. & Huovinen, P. (1993). Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J Antimicrob Chemother 32, 885-891.
10. Seppälä, H., Skurnik, M., Soini, H., Roberts, M. C. & Huovinen, P. (1998). A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes. Antimicrob Agents Chemother 42, 257-262.
11. Sutcliffe, J., Grebe, T., Tait-Kamradt, A. & Wondrack, L. (1996). Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother 40, 2562-2566.
12. Traub, W. H. & Leonhard, B. (1997). Comparative susceptibility of clinical group A, B, C, F, and G β-hemolytic streptococcal isolates to 24 antimicrobial drugs. Chemotherapy 43, 10-20.